Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel pseudogene KIAA1191 (ENSG00000237606) is a DNA sequence annotated in the human genome that shares sequence homology with the KIAA1191 gene but is characterized as a pseudogene, meaning it does not produce a functional protein product. Pseudogenes like this are typically formed through gene duplication or retrotransposition, followed by mutations that disrupt protein-coding ability. While some pseudogenes have been shown to play roles in the regulation of their parent genes or have RNA-based biological functions, there is no demonstrated function or role for this particular pseudogene. As such, it is not considered a therapeutic target or involved in known pharmacological or disease pathways.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel pseudogene KIAA1191 (ENSG00000237606).